-
-
-
-
-
-
-
Venture Global closes $15.1 billion financing for CP2 LNG phase 1
-
-
-
-
-
-
-
UroGen publishes phase 3b study on home treatment for bladder cancer
-
-
-
-
-
-
-
Compugen to present COM701 ovarian cancer trial data at ESMO conference
-
-
-
-
-
-
-
Evaxion to present two-year data on cancer vaccine at ESMO Congress
-
-
-
-
-
-
-
Sarepta's Elevidys Fails to Get EU Approval - Bloomberg
-
-
-
-
-
-
-
CervoMed to share phase 2b study results at conference call july 28
-
-
-
-
-
-
-
IDEAYA to present darovasertib trial data at ESMO 2025 conference
-
71,349 total articles have been posted to this category.
Sign-up to StreetInsider.com Premium
to see all today's market moving FDA reports.